However, many healthcare professionals support them because of good results seen with their drug versions
Here is what went into this page specifically: I pulled the full text of the SURMOUNT-5 head-to-head trial published in the New England Journal of Medicine on May 11, 2025 (DOI: 10.1056/NEJMoa2416394) and cross-referenced it with the Phase 3 TRIUMPH-4 topline readout from Eli Lilly on December 11, 2025
they are not FDA-approved as finished products, but they contain the same active ingredients (semaglutide, tirzepatide) found in Wegovy, Ozempic, Zepbound, and Mounjaro
Those dosages havent been studied in large, long-term clinical trials
Providers located via this service may recommend a range of care options, including medications
The two innovations expand the startups product line to seven, indicating the depth of consideration that goes into each piece of NPD for the five-year-young brand